Module 3: Navigating Controversy: Prognostic Factors, Breakthroughs, and Biomarkers

This module will focus on topics of debate in the MS arena including best practices in DMT switching, the impact of race and pregnancy on DMT choice, and the potential role of neurofilament light (NfL) in routine practice. 

Target Audience

This activity is intended for neurologists, nurse practitioners, physician assistants, pharmacists, and other providers involved in the care of patients with MS.

Learning Objectives

  • Assess the potential impact of specific prognostic and clinical factors (e.g. pregnancy, race, OCT findings) to assist in the development of individualized treatment plans for patients with MS.
  • Assess clinical investigator perspectives regarding breakthrough disease management, including the indications for DMT discontinuation and/or switching in individuals receiving active treatment, to inform these decisions in clinical practice.
  • Recognize the potential clinical role of emerging biomarkers (e.g., neurofilament light chain) to assist in the diagnosis, risk stratification and/or identification of disease progression of patients with MS.
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™
Course opens: 
07/28/2020
Course expires: 
07/31/2021
Cost:
$0.00
Rating: 
0

 
 
 
  Robert Bermel, MD
  Staff Neurologist and
  Director, Mellen Center for Multiple Sclerosis
  Cleveland Clinic
  Cleveland, Ohio
 
Dr. Bermel is a board certified neurologist and the director of the Mellen Center for Multiple Sclerosis (MS) at the Cleveland Clinic. He is widely recognized for his contributions to the field of neurology with a particular focus on MS research. He is actively involved at the forefront of pharmacological and technological advancement in MS and has been a frequent presenter of such advances at ACTRIMS and ECTRIMS as well as a consulting authority throughout the field.

 

 
 
 
  James Stankiewicz, MD
  Assistant Professor of Neurology
  Harvard Medical School
  Clinical Director, Partners Multiple Sclerosis Center
  Boston, Massachusetts
 
Dr. Stankiewicz is an assistant professor of neurology at Harvard Medical School and the clinical director for the Partners Multiple Sclerosis Center. He is involved in both medical and charitable endeavors among the MS community with current positions serving as topic co-chair at the American Academy of Neurology's annual meeting for MS and CNS Inflammatory Disease as well as on the medical advisory board of The Assistance Fund. He additionally co-edits the broadly utilized textbook, Multiple Sclerosis: Principles of Diagnosis and Treatment, helping to guide practicing physicians across the field.

 

 
 
 
  Adnan Subei, DO
  Medical Director, Multiple Sclerosis Program
  Memorial Healthcare System Neuroscience Institute
  Hollywood, Florida 
 
Dr. Subei is a board certified neurologist and medical director for the MS program at Memorial Healthcare System Neuroscience Institute. Has been awarded multiple fellowship grants from the American Academy of Neurology and the National Multiple Sclerosis Society and specialized in both neuro-visual and neuro-immunological disorders. He continues an active interest in research while at Memorial Healthcare where he has been since completing his fellowship at the Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research.
Estimated Credit Hours
Postgraduate Institute for Medicine will provide up to 0.75 AMA PRA Category 1 Credits™ to learners for their participation in the web-based elements of the activity.

 
 
 
 
About PIM
The Postgraduate Institute for Medicine (PIM) has been providing trusted independent continuing education for healthcare professionals for over 35 years and is a recognized leader for jointly provided CME/CE activities. The purpose of the PIM continuing healthcare education program is to deliver effective CME/CE activities that are designed to contribute to the professional development of physicians and other healthcare professionals, support the development and function of collaborative interprofessional teams, and positively impact the delivery of healthcare. We fulfill this mission by forming successful alliances and working in collaboration to deliver impactful educational experiences that are designed to improve patient care practices.

In support of improving patient care, PIM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. PIM is one of a very select group of jointly accredited providers that has been awarded the highest level of a 6-year term, placing PIM among the top echelon of CME/CE providers that have demonstrated the highest levels of educational acumen in providing healthcare professionals with relevant, effective, practice-based continuing education that supports US health care quality improvement.
 
PIM is also accredited by the American Academy of Physician Assistants (AAPA), the Association of Regulatory Boards of Optometry's Council on Optometric Practitioner Education (ARBO/COPE), the Association of Social Work Boards (ASWB), the International Association for Continuing Education and Training (IACET), the Commission on Dietetic Registration (CDR), the American Psychological Association (APA) as a sponsor of CE for psychologists and the American Dental Association (ADA) as a Continuing Education Recognition Program (CERP) recognized provider. PIM is authorized to award pre-approved Qualified Education credit by the American College of Healthcare Executives (ACHE) and is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Sciences’ Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program.
 
PIM is composed of a staff of dedicated professionals who represent a unique blend of educational and clinical talent, as well as statistics acumen. Eight (8) of these individuals are Certified Healthcare Continuing Professional Development Professionals (CHCPs), and 3 PIM staff members hold clinical degrees, including 2 PharmDs and 1 master’s prepared registered nurse. The PIM team is rounded out by a PhD researcher with expertise in adult learning principles and outcomes analysis and a biostatistician that holds a master’s degree in public health statistics.

Available Credit

  • 0.75 AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.